Andere talen Chimerix, Inc.

Aandelen

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 01-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,95 ^USD	+1,06%		+2,67%	-1,30%

21/03	Chimerix benoemt Marc D. Kozin tot lid van de Raad van Bestuur	CI
29/02	Transcript : Chimerix, Inc., Q4 2023 Earnings Call, Feb 29, 2024

Chimerix: Q1 Earnings Snapshot	13:34
Chimerix Reports First Quarter 2024 Financial Results and Provides Operational Update	13:01
Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024	24/04
Chimerix Reports Inducement Grants under Nasdaq Listing Rule 5635(4)	17/04
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	16/04
Chimerix Appoints Marc D. Kozin to Board of Directors	21/03
Chimerix Appoints Marc D. Kozin to Board of Directors	21/03
Chimerix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
Chimerix, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29/02
Chimerix: Q4 Earnings Snapshot	29/02
Earnings Flash (CMRX) CHIMERIX Reports Q4 Revenue $4,000, vs. Street Est of $70,000	29/02
Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update	29/02
Chimerix to Present at TD Cowen 44th Annual Health Care Conference	27/02
Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024	22/02
Chimerix Announces Board Changes	29/12
Chimerix Appoints Lisa Decker to Board of Directors	29/12
Chimerix Names Michelle LaSpaluto Finance Chief	04/12
Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer	04/12
Chimerix, Inc. Promotes Michelle Laspaluto to the Position of Chief Financial Officer	04/12
Chimerix Reports Inducement Grant under Nasdaq Listing Rule 5635(4)	27/11

Geen resultaten voor deze zoekopdracht